Topic - Diana Zuckerman

Subscribe to this topic via RSS or ATOM
Related Stories
  • Hip implants a bit more likely to fail in women

    Hip replacements are slightly more likely to fail in women than in men, according to one of the largest studies of its kind in U.S. patients. The risk of the implants failing is low, but women were 29 percent more likely than men to need a repeat surgery within the first three years.

More Stories →

Quotations
  • "They imply that the FDA approval decision isn't that important in deciding how this test will be used," said Diana Zuckerman, president of the Cancer Prevention and Treatment Fund. "By claiming to pass the buck to the experts in the field, FDA is not taking responsibility for the agency's influential decision to approve the test as a replacement of the Pap smear for women over 25."

    FDA OKs first-ever DNA alternative to Pap smear →

  • "Unfortunately the HPV test by itself isn't very useful because so many young women have HPV that will disappear without any treatment," said Diana Zuckerman of the Cancer Prevention and Treatment Fund. "Having an HPV test without also getting a Pap smear to check for problems is going to scare a lot of women who are not developing cervical cancer."

    DNA alternative to Pap smear sparks medical debate →

Happening Now